| Shareholder | |||||
|---|---|---|---|---|---|
Sihuan Pharmaceutical Holdings Group Ltd. | 49.13% | 254.45M | 0.00% | +0 | |
CS Capital Co., Ltd. | 13.52% | 70.03M | 0.00% | +0 | |
Tianjin Zhenxuan Pharmaceutical Technology Partnership (Limited Partnership) | 6.96% | 36.05M | 0.00% | +0 | |
SDIC Innovation Investment Management Co., Ltd. | 4.51% | 23.34M | 0.00% | +0 | |
Beihai Baimeien Investment Partnership (Limited Partnership) | 2.52% | 13.04M | 0.00% | +0 | |
Beihai Jixin Xuanzhu Investment Partnership (Limited Partnership) | 1.63% | 8.47M | 0.00% | +0 | |
Yanjun XuGM & Executive Chairman of the Board | 0.91% | 4.71M | 0.00% | +0 | |
Beihai Keya Xuanzhu Investment Partnership (Limited Partnership) | 0.74% | 3.85M | 0.00% | +0 | |
Jiakui LiExecutive Director | 0.58% | 3.02M | 0.00% | +0 | |
Cheng-Kon ShihExecutive Director | 0.33% | 1.70M | 0.00% | +0 | |
Fengsheng Che | 0.24% | 1.24M | -- | +1.24M | |
Weicheng Guo | 0.08% | 407.71K | -- | +407.71K | |
Xianhui Meng | 0.03% | 138.30K | -- | +138.30K | |
Jionglong Zhang | 0.02% | 93.69K | -- | +93.69K | |
State Street Investment Management | <0.01% | 7.50K | -- | +7.50K |
